VAERS Explorer
Back to explore

Report #2846751

Received Jun 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NJ
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (2)

Circumstance or information capable of leading to medication errorExtra dose administered

Symptom narrative

second dose of Boostrix will be administered today; second dose of Boostrix will be administered today June 10, 2025; A female patient received the first dose of Boostrix on April 24, 2025 and is intended to get the second dose on June 10, 2025.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of circumstance or information capable of leading to medication error in a 37-year-old female patient who did not receive DTPa (Reduced antigen) (Boostrix) for prophylaxis. Concomitant products included Diphtheria vaccine toxoid, Pertussis vaccine acellular 3-component, Tetanus vaccine toxoid (Boostrix). The patient did not receive Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced circumstance or information capable of leading to medication error (Verbatim: second dose of Boostrix will be administered today), extra dose administered (Verbatim: second dose of Boostrix will be administered today June 10, 2025) and drug prescribing error (Verbatim: A female patient received the first dose of Boostrix on April 24, 2025 and is intended to get the second dose on June 10, 2025.). The outcome of the circumstance or information capable of leading to medication error, extra dose administered and drug prescribing error were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 10-JUN-2025 On 10/ June/2025 a pharmacist called to ask two questions for two different patients: The first patient is a female and received Boostrix on April 24, 2025. Physician prescribed a 3 dose series of Boostrix which led to drug prescribing error and because the patient never had Boostrix before. The second dose of Boostrix will be administered today June 10, 2025, and 3rd dose will be administered 6 months later, this led to circumstance or information capable of leading to medication error and extra dose administered. Is there any information of primary series of Boostrix for unvaccinated adults.

Other medications

BOOSTRIX